Clinical significance of Philadelphia‐like‐related genes in a resource‐constrained setting of adult B‐acute lymphoblastic leukemia patients

• Keli Lima,
• César Alexander Ortiz Rojas,
• Frederico Lisboa Nogueira,
• Wellington Fernandes da Silva,
• Rita de Cássia Cavaglieri,
• Luciana Nardinelli,
• Aline de Medeiros Leal,
• Elvira Deolinda Rodrigues Pereira Velloso,
• Israel Bendit,
• Alvaro Alencar,
• Charles G. Mullighan,
• João Agostinho Machado‐Neto,
• Eduardo Magalhães Rego

Affiliations

Keli Lima

Department of Internal Medicine, Hematology Division, Laboratory of Medical Investigation in Pathogenesis and Targeted Therapy in Onco‐Immuno‐Hematology (LIM‐31), Faculdade de Medicina University of São Paulo Sao Paulo Brazil

César Alexander Ortiz Rojas

Department of Internal Medicine, Hematology Division, Laboratory of Medical Investigation in Pathogenesis and Targeted Therapy in Onco‐Immuno‐Hematology (LIM‐31), Faculdade de Medicina University of São Paulo Sao Paulo Brazil

Frederico Lisboa Nogueira

Department of Internal Medicine, Hematology Division, Laboratory of Medical Investigation in Pathogenesis and Targeted Therapy in Onco‐Immuno‐Hematology (LIM‐31), Faculdade de Medicina University of São Paulo Sao Paulo Brazil

Wellington Fernandes da Silva

Department of Internal Medicine, Hematology Division, Laboratory of Medical Investigation in Pathogenesis and Targeted Therapy in Onco‐Immuno‐Hematology (LIM‐31), Faculdade de Medicina University of São Paulo Sao Paulo Brazil

Rita de Cássia Cavaglieri

Department of Internal Medicine, Hematology Division, Laboratory of Medical Investigation in Pathogenesis and Targeted Therapy in Onco‐Immuno‐Hematology (LIM‐31), Faculdade de Medicina University of São Paulo Sao Paulo Brazil

Luciana Nardinelli

Department of Internal Medicine, Hematology Division, Laboratory of Medical Investigation in Pathogenesis and Targeted Therapy in Onco‐Immuno‐Hematology (LIM‐31), Faculdade de Medicina University of São Paulo Sao Paulo Brazil

Aline de Medeiros Leal

Department of Internal Medicine, Hematology Division, Laboratory of Medical Investigation in Pathogenesis and Targeted Therapy in Onco‐Immuno‐Hematology (LIM‐31), Faculdade de Medicina University of São Paulo Sao Paulo Brazil

Elvira Deolinda Rodrigues Pereira Velloso

Department of Internal Medicine, Hematology Division, Laboratory of Medical Investigation in Pathogenesis and Targeted Therapy in Onco‐Immuno‐Hematology (LIM‐31), Faculdade de Medicina University of São Paulo Sao Paulo Brazil

Israel Bendit

Department of Internal Medicine, Hematology Division, Laboratory of Medical Investigation in Pathogenesis and Targeted Therapy in Onco‐Immuno‐Hematology (LIM‐31), Faculdade de Medicina University of São Paulo Sao Paulo Brazil

Alvaro Alencar

Sylvester Comprehensive Cancer Center University of Miami Miller School of Medicine Miami Florida USA

Charles G. Mullighan

Department of Pathology St. Jude Children's Research Hospital Memphis Tennessee USA

João Agostinho Machado‐Neto

Department of Pharmacology, Institute of Biomedical Sciences University of São Paulo Sao Paulo Brazil

Eduardo Magalhães Rego

Department of Internal Medicine, Hematology Division, Laboratory of Medical Investigation in Pathogenesis and Targeted Therapy in Onco‐Immuno‐Hematology (LIM‐31), Faculdade de Medicina University of São Paulo Sao Paulo Brazil